Technical Data
BD1, Recombinant, Human (beta Defensin-1)
Molecular Biology Storage: -20CShipping: Blue Ice

Source: HBD-1 was expressed in E. coli, refolded and purified

< 0.1ng/ug (1.0EU/ug)

Biological Activity:
The HBD-1 recombinant protein activity was determined by its ability to chemoattract human peripheral blood dendritic cells using a concentration range of 100-1000ng/ml

Antimicrobial peptides are a common mechanism of host defense utilized by a variety of species, from insects to humans. Defensins are a large family of broad-spectrum antimicrobial peptides, identified originally in leukocytes of rabbits and humans. Defensins, cationic/polar peptides (30-35 aa; 3-4kD), are distinguished by a conserved tri-disulfides and a largely b-Sheet structure. Defensins, expressed at the cell surface, have been hypothesized to function as a biochemical barrier against microbial infection by inhibiting colonization of the epithelium by wide range of pathogenic microorganisms. In leukocytes, these peptides are stored in cytoplasmic granules and are released into phagolysosomes where they contribute to the killing of engulfed microorganisms.

The genes encoding human alpha and beta-defensins are clustered in a contiguous segment of chromosome 8p23. Defensins are classified into two families designated alpha and beta based on distinctive, although similar, tri-disulfide linkages in the peptides. b-defensins are slightly larger and differ in the position and arrangement of 3 disulfides. In humans, six a-defensin (cryptidins), HD 1-6 (HD1-4 are also known as HNP1-4 for Human Neutrophil Peptides), and two b-defensins, HBD-1 and HBD-2, have been identified.

Alpha-defensins are encoded by genes designated DEFA1-6, whereas human b-defensins are encoded by the DEFB1 and DEFb2 genes. HD1-4 are expressed in neutrophils, whereas HD5 and HD6 are expressed in epithelial cells of the intestinal and reproductive tract. HD1-3/HNP1-3 make up about 30% of the neutrophil's total granule protein. The HNPs are 29 to 30 amino acids long and are identical in sequence except at the N-terminal amino acid. DEFA1 and DEFA3 differ from each other only by their terminal ala and asp, respectively. DEFA2 is identical to both except that it has 29 instead of 30 amino acids.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Molecular Weight:
Source: HBD-1 was expressed in E. coli, refolded and purified
Purity: 98% 0.1ng/ug (1.0EU/ug).
Concentration: ~1mg/ml
Form: Supplied as a lyophilized powder from 10mM acetic acid.
Reconstitute with 10mM acetic acid to 01-1mg/ml. Further dilutions in appropriate buffers.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
1. Huttner, K.M., et al., FEBS Lett. 413: 45-69 (1997). 2. Liu, L., et al., Genomics 43: 316-320 (1997). 3. McCray, P.B., et al., Am. J. Respir. Cell. Mol. Biol. 16: 343-349 (1997). 4. Bensch, K.W., et al., FEBS Lett. 368: 331-335 (1995). 5. Bartels, J., et al., Nature 387: 861 (1997). 6. Ganz, T., Science 286: 420 (1999). 7. Yang, D., et al., Science 286: 525 (1999).

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.